Alphafold2 - OmicsDI

Show results for

Unknown (993)
Proteomics (42)
Genomics (27)
Transcriptomics (4)
Other (1)

Organisms

Aerococcus urinae NBRC 15544 = CCUG 36881 (37)
Andropogon gerardi (37)
Bacteria (37)
Bartonella quintana JK 31 (37)
Canis lupus familiaris (37)
Cnidaria (37)
Ectopseudomonas oleovorans CECT 5344 (37)
Ensifer adhaerens (37)
Halictus scabiosae (37)
Human immunodeficiency virus 1 (37)
Mesocricetus auratus (37)
Methylohalobius crimeensis 10Ki (37)
Miscanthus x giganteus (37)
Mus musculus (37)
Panicum virgatum (37)
Pseudomonas aeruginosa SJTD-1 (37)
Rabies virus Nishigahara RCEH (37)
Rattus norvegicus (37)
Rattus rattus (37)
Rhodococcus jostii RHA1 (37)
Rhodopseudomonas palustris (37)
Schizosaccharomyces pombe 927 (37)
Sorghastrum nutans (37)
Homo sapiens (5)
Mus musculus (2)
Saccharomyces mikatae (1)
Solanum lycopersicum (1)
synthetic construct (1)
Saccharomyces cerevisiae (1)
Escherichia coli (1)

Organisms

Homo sapiens (5)
synthetic construct (2)
Mus musculus (2)

Repository

pride (37)
ENA (22)
geo (10)
MassIVE (4)
jPOST (1)

Tissue

Cell culture (7)
Cell suspension culture (3)
Liver (2)
Plant cell (2)
Brain (1)
Eggshell (1)
HeLa cell (1)
HiPSC cell (1)
Muscle (1)
Permanent cell line cell (1)
Photosynthetic cell (1)
Shoot (1)
Sperm (1)
T cell (1)
Testis (1)

Technology Type

Mass Spectrometry (37)
Chemical cross-linking coupled with mass spectrometry proteomics (10)
Data-dependent acquisition (9)
Bottom-up proteomics (8)
Shotgun proteomics (7)
Affinity purification coupled with mass spectrometry proteomics (4)
Data-independent acquisition (3)
SWATH MS (3)
Gel-based experiment (2)
MSE (2)
SRM/MRM (1)

Instrument Platform

Orbitrap Fusion Lumos (2)
LTQ Orbitrap Velos (1)
Orbitrap Eclipse (1)

First Public Date

2023 (8)
2024 (5)
2026 (4)
2025 (4)
2022 (1)

Release Date

2024 (279)
2023 (259)
2025 (245)
2022 (157)
2021 (27)
2026 (26)

Lab affiliation

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (5)
1. University College London 2. Birkbeck (1)
CRG, UPF (1)
Core Facility for Mass Spectrometry and Proteomics, Center for Molecular Biology of Heidelberg University (1)
Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark (1)
Department of Biomolecular Medicine, Ghent University, 9052 Ghent, Belgium. Center for Medical Biotechnology, VIB, 9052 Ghent, Belgium. (1)
Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California, USA. (1)
Department of Life Sciences and Systems Biology University of Turin Italy (1)
Dept. Cellular Molecular Pharmacology, University of California - San Francisco (UCSF), USA (1)
ETH Zürich (1)
European Molecular Biology Laboratory 71 Av. des Martyrs, 38000 Grenoble France (1)
Fudan University Shanghai Cancer Center from China (1)
Ghent University, Department of Plant Biotechnology and Bioinformatics, Technologiepark 71, 9052 Ghent, Belgium VIB Center for Plant Systems Biology, Technologiepark 71, 9052 Ghent, Belgium (1)
IMB, Ackermannweg 4, 55128 Mainz (1)
Institute of Aerospace Medicine German Aerospace Center (DLR) Linder Höhe 51147 Cologne, Germany & Institute for Genome Stability in Ageing and Disease University of Cologne CECAD Research Center Joseph-Stelzmann-Str. 26 50931 Cologne, Germany & Max-Planck Institute of Biochemistry Am Klopferspitz 18 82152 Martinsried, Germany (1)
Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland (1)
Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 3BX, United Kingdom (1)
Laboratory of Gene Expression and Cancer, GIGA-Molecular & Computational Biology, University of Liège, 4000 Liège, Belgium (1)
Light, Photosynthesis & Metabolism (LPM) & Exploring the Dynamics of Proteomes (EDyP) IRIG, CEA-Grenoble 17 rue des Martyrs, 38000 Grenoble, France (1)
MSAP UAR 3290 Bat C4 avenue Paul Langevin 59655 Villeneuve d'ascq (1)
Mass Spectrometry Laboratory IBB PAS (1)
Max-Planck Institute of Biophysics (1)
Molecular Structure of Cell Signalling Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK (1)
Principle investigator (1)
School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia Queensland 4072, Australia ARC Industry Transformation Training Centre for Cryo-electron Microscopy of Membrane Proteins Institute for Molecular Bioscience, The University of Queensland, St Lucia Queensland 4072, Australia (1)
Technische Universität Berlin, Chair of Bioanalytics, 10623 Berlin, Germany Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK Si-M/"Der Simulierte Mensch", a Science Framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany (1)
The Rockefeller University (1)
The Wistar Institute, 3601 Spruce St, Philadelphia, PA 19103, USA (1)
UCL (1)
University of California, Irvine (1)

Publication date

2025 (19)
2023 (15)
2024 (13)
2022 (5)

Tags

xref:PubMed:36920904 (3)
xref:PubMed:41851108 (1)
xref:PubMed:37978291 (1)
xref:PubMed:36488193 (1)
xref:PubMed:37498744 (1)

Previous page
1 / 107
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 107
Next page

Sort by:

Relevance

Page size

Modeling flexible protein structure with AlphaFold2 and cross-linking mass spectrometry

We propose a pipeline that combines AlphaFold2 (AF2) and crosslinking mass spectrometry (XL-MS) to model the structure of proteins with multiple conformations. The pipeline consists of two main steps: ensemble generation using AF2, and conformer selection using XL-MS data. For conformer selection, w...

ORGANISM(S): Escherichia coli

2024-05-24 | PXD046392 | Pride

Nanopore sequencing combining AlphaFold2 identifies alternative splicing derived putative neoantigens in uveal melanoma

PRJNA851027 | ENA

Nanopore sequencing combining AlphaFold2 identifies alternative splicing derived putative neoantigens in uveal melanoma

We employed a hybrid method based on Oxford Nanopore long-read sequencing and Illumina sequencing to characterize the AS landscapes, and to identify AS-derived neoantigens. Furthermore, we used the AlphaFold2 algorithm to analyze the structure of these putative neoantigens, thus offering structural ...

ORGANISM(S): Homo sapiens

2023-08-02 | GSE206464 | GEO

Empowering AlphaFold2 for protein conformation selective drug discovery with AlphaFold2-RAVE.

Not available

S-EPMC11379456 | biostudies-literature

Empowering AlphaFold2 for protein conformation selective drug discovery with AlphaFold2-RAVE.

Not available

S-EPMC11042445 | biostudies-literature

NMR hawk-eyed view of AlphaFold2 structures.

Not available

S-EPMC8521308 | biostudies-literature

Benchmarking AlphaFold2 on peptide structure prediction.